November 2020

UROLOGY

INVESTIGATING THE CLINICAL AND MOLECULAR BIOLOGY OF HIGH-RISK PROSTATE CANCER

Featuring: Edward M. Schaeffer, MD, PhD

Episode Summary

The laboratory of Edward M. Schaeffer, MD, PhD, chair in the Department of Urology at Northwestern Medicine and program director of the Genitourinary Oncology Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, has brought international recognition to the previously under appreciated observation that aggressive, localized prostate cancer is frequently lethal and often under treated. Dr. Schaeffer is conducting research to identify the molecular mechanisms associated with aggressive prostate cancer, which will permit the exploration of effective therapeutic modalities and development of robust biomarkers for treatment intensification and improved clinical outcomes. In this video, he shares details about the future direction of this work. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like